Prodotto aggiunto correttamente al carrello.

discount label
Ac-CTPYDINQM-NH2
Visualizzare in 3D

Biosynth logo

Ac-CTPYDINQM-NH2

Rif. 3D-PP47623

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Lunedì 16 Dicembre 2024

Informazioni sul prodotto

Nome:
Ac-CTPYDINQM-NH2
Descrizione:

Peptide Ac-CTPYDINQM-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-CTPYDINQM-NH2 include the following: virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class ZW Chen, A Craiu, L Shen, MJ Kuroda - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/164/12/6474/33112 Simian Immunodeficiency Virus (SIV) Infection of a Rhesus Macaque Induces SIV-Specific CD8+ T Cells with a Defect in Effector Function That Is Reversible on Y Xiong, MA Luscher, JD Altman , M Hulsey - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.6.3028-3033.2001 Clonally diverse CTL response to a dominant viral epitope recognizes potential epitope variants WA Charini, MJ Kuroda , JE Schmitz - The Journal of , 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/9/4996/42711 Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified TM Allen , TU Vogel, DH Fuller , BR Mothe - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/164/9/4968/33032 Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A* 01) that binds an immunodominant CTL epitope from simian TM Allen , J Sidney , MF del Guercio - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/12/6062/43834 CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility TM Allen , BR Mothé, J Sidney , P Jing, JL Dzuris - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.2.738-749.2001 Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts TC Friedrich , AB McDermott , MR Reynolds - Journal of , 2004 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.78.18.10064-10073.2004 Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus T Swigut, L Alexander, J Morgan, J Lifson - Journal of , 2004 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.78.23.13335-13344.2004 Disentangled Wasserstein Autoencoder for T-Cell Receptor Engineering T Li , H Guo , F Grazioli , M Gerstein - Advances in Neural , 2024 - proceedings.neurips.cchttps://proceedings.neurips.cc/paper_files/paper/2023/hash/e95da8078ec8389533c802e368da5298-Abstract-Conference.html Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia T Hanke , RV Samuel, TJ Blanchard - Journal of , 1999 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.73.9.7524-7532.1999 Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine RR Amara , F Villinger, JD Altman , SL Lydy, SP O'Neil - Science, 2001 - science.orghttps://www.science.org/doi/abs/10.1126/science.292.5514.69 HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other PJR Goulder , Y Tang, SI Pelton, BD Walker - Journal of virology, 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.11.5291-5299.2000 Novel Application of Nonhuman Primate Tethering System for Evaluation of Acute Phase SIVmac251 Infection in Rhesus Macaques (Macaca mulatta) MS Keckler, VL Hodara , LM Parodi - Viral immunology, 2007 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.2007.0068 CD8+ T-Lymphocyte Response to Major Immunodominant Epitopes after Vaginal Exposure to Simian Immunodeficiency Virus: Too Late and Too Little MR Reynolds , E Rakasz , PJ Skinner , C White - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.79.14.9228-9235.2005 Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian MJ Cayabyab, B Korioth-Schmitz , Y Sun - Journal of , 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02544-08 The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A* 01 class I molecule M Furchner, AL Erickson, T Allen , DI Watkins - Journal of , 1999 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.73.10.8035-8039.1999 Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding LC Walters, K Harlos , S Brackenridge - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-05459-z A high frequency of Mamu-A *01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing LA Knapp , E Lehmann, MS Piekarczyk - Tissue , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-0039.1997.tb02927.x Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa JP Nkolola, EGT Wee, EJ Im, CP Jewell, N Chen - Gene therapy, 2004 - nature.comhttps://www.nature.com/articles/3302241 The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and J Liu , Y Sun , J Qi, F Chu , H Wu, F Gao - The Journal of , 2010 - academic.oup.comhttps://academic.oup.com/jid/article-abstract/202/8/1171/926918 Comparison of Vibratome and Compresstome sectioning of fresh primate lymphoid and genital tissues for in situ MHC-tetramer and immunofluorescence staining HM Abdelaal , HO Kim, R Wagstaff, R Sawahata - Biological procedures , 2015 - Springerhttps://link.springer.com/article/10.1186/s12575-014-0012-4 Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection GH Mylvaganam, D Rios - Proceedings of the , 2017 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1621418114 First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A* 01 complexed with two immunogenic SIV epitopes and F Chu , Z Lou, YW Chen , Y Liu, B Gao - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/178/2/944/37482 Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A* 01 complexed with an immunodominant F Chu , Z Lou, B Gao, JI Bell , Z Rao - Section F: Structural , 2005 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?S1744309105016453 Collapse of cytolytic potential in SIV-specific CD8+ T cells following acute SIV infection in rhesus macaques ER Roberts, DG Carnathan, H Li, GM Shaw - PLoS , 2016 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006135 Dominant CD8+ T-Lymphocyte Responses Suppress Expansion of Vaccine-Elicited Subdominant T Lymphocytes in Rhesus Monkeys Challenged with Pathogenic ER Manuel, WW Yeh, MS Seaman, K Furr - Journal of , 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01015-09 Reduction of simian-human immunodeficiency virus 89.6 P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination DH Barouch , S Santra, MJ Kuroda , JE Schmitz - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.11.5151-5158.2001 Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys DH Barouch , A Craiu, MJ Kuroda - Proceedings of the , 2000 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.050417697 Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication DA Garber, G Silvestri , AP Barry - The Journal of , 2004 - Am Soc Clin Investighttps://www.jci.org/articles/view/19442 Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development? D O'Connor , T Allen , DI Watkins - Immunology letters, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247801002681 Induction of AIDS Virus-Specific CTL BM Altman, AJ McMichael, I David, JF Shipley, T Hanke - J Immunol, 2000 - academia.eduhttps://www.academia.edu/download/38260542/4968.pdf virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide A Seth, I Ourmanov, MJ Kuroda - Proceedings of the , 1998 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.95.17.10112

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP47623 Ac-CTPYDINQM-NH2

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".